Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Pre-Transplant Autonomic Nervous System Malfunction Is a Powerful Predictor for Survival after Allogeneic Hematopoietic Cell Transplantation

Takahiko Nakane, MD, PhD, Mika Nakamae, MD,PhD, Hideo Koh, MD,PhD, Mitsutaka Nishimoto, MD,PhD, Yoshiki Hayashi, MD,PhD, Asao Hirose, MD,PhD, Yasuhiro Nakashima, MD,PhD, Masayuki Hino, Hirohisa Nakamae, MD,PhD

Blood (2015) 126 (23): 3205.

https://doi.org/10.1182/blood.V126.23.3205.3205

Published: 2015

Journal Articles

Effectiveness of Antibacterial Prophylaxis with Non-Absorbable Polymyxin B Compared to Levofloxacin after Allogeneic Hematopoietic Stem Cell Transplantation

Shiro Koh, MD, Hirohisa Nakamae, Koichi Yamada, MD, PhD, Mitsutaka Nishimoto, MD, PhD, Yoshiki Hayashi, MD, PhD, Hideo Koh, MD, PhD, Yasuhiro Nakashima, MD, PhD, Takahiko Nakane, MD, PhD, Asao Hirose, MD, PhD, Mika Nakamae, MD, PhD, Hiroshi Kakeya, MD, PhD, Masayuki Hino, MD, PhD

Blood (2014) 124 (21): 1145.

https://doi.org/10.1182/blood.V124.21.1145.1145

Published: 2014

Journal Articles

The V50/V25 Ratio, a Marker of Small Airway Disease, Is Highly Predictive of Survival after Allogeneic Hematopoietic Cell Transplantation

Mika Nakamae, MD, PhD, Hirohisa Nakamae, Mariko Yamashita, Mitsutaka Nishimoto, MD, PhD, Yoshiki Hayashi, MD, PhD, Hideo Koh, MD, PhD, Takahiko Nakane, MD, PhD, Yasuhiro Nakashima, MD, PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD

Blood (2014) 124 (21): 1208.

https://doi.org/10.1182/blood.V124.21.1208.1208

Published: 2014

Journal Articles

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Yoshiki Hayashi, M.D., Hirohisa Nakamae, MD, PhD, Takako Katayama, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Mitsutaka Nishimoto, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2011) 118 (21): 3764.

https://doi.org/10.1182/blood.V118.21.3764.3764

Published: 2011

Journal Articles

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Mitsutaka Nishimoto, M.D., Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Ph.D., Hideo Koh, M.D., Ph.D, Yoshiki Hayashi, M.D., Mika Nakamae, M.D., Ph.D, Masahiro Yoshida, M.D., Masato Bingo, M.D., Hiroshi Okamura, M.D., Mizuki Aimoto, M.D., Masahiro Manabe, M.D., Takuro Yoshimura, M.D., Akiko Inaba, M.D., Satoshi Nanno, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D, Yoshitaka Nakao, M.D., Ph.D, Yoshiki Terada, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2011) 118 (21): 2000.

https://doi.org/10.1182/blood.V118.21.2000.2000

Published: 2011

Journal Articles

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Blood (2010) 116 (21): 3551.

https://doi.org/10.1182/blood.V116.21.3551.3551

Published: 2010

Journal Articles

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD, PhD, Hideo Koh, MD, Mika Nakamae, MD, PhD, Yoshiki Hayashi, MD, Mitsutaka Nishimoto, MD, Takuro Yoshimura, MD, Eri Inoue, MD, Atsushi Inoue, MD, Ran Aimoto, MD, Mizuki Aimoto, MD, Yoshiki Terada, MD, PhD, Ki-Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Masayuki Hino, MD, PhD

Blood (2009) 114 (22): 4347.

https://doi.org/10.1182/blood.V114.22.4347.4347

Published: 2009

Journal Articles

Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated ( ATM ) gene in childhood Hodgkin disease

Masatoshi Takagi, Rika Tsuchida, Kaoru Oguchi, Teruko Shigeta, Shinichiro Nakada, Kimiko Shimizu, Misao Ohki, Domenico Delia, Luciana Chessa, Yoichi Taya, Makoto Nakanishi, Yukiko Tsunematsu, Fumio Bessho, Keiichi Isoyama, Yoshiki Hayashi, Kazuko Kudo, Jun Okamura, Shuki Mizutani

Blood (2004) 103 (1): 283–290.

https://doi.org/10.1182/blood-2003-01-0094

Published: 2004

NARROW

Pre-Transplant Autonomic Nervous System Malfunction Is a Powerful Predictor for Survival after Allogeneic Hematopoietic Cell Transplantation

Effectiveness of Antibacterial Prophylaxis with Non-Absorbable Polymyxin B Compared to Levofloxacin after Allogeneic Hematopoietic Stem Cell Transplantation

The V50/V25 Ratio, a Marker of Small Airway Disease, Is Highly Predictive of Survival after Allogeneic Hematopoietic Cell Transplantation

Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib,

Risk Factors Affecting Cardiac Left Ventricular Systolic and Diastolic Function and Hypertrophy in the Chronic Phase Post-Allogeneic Hematopietic Cell Transplantation

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated ( ATM ) gene in childhood Hodgkin disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only